1.11. Analysis.
Comparison 1: Single immunecheckpoint inhibitors vs chemotherapy, Outcome 11: Overall survival by histological type (PDL1≥ 1%)
Comparison 1: Single immunecheckpoint inhibitors vs chemotherapy, Outcome 11: Overall survival by histological type (PDL1≥ 1%)